LNK International, Inc.

4 FDA enforcement actions

4 Total Recalls

0 Class I

1 Class II

3 Class III

Firm Details

Product Types: drug
States: NY

All Recalls

Class II: Risk 11/14/2024 drug

CGMP Deviations: Released product should have been rejected.
Class III: Low Risk 10/11/2022 drug

Boxes mislabeled to read "Decongestant Free", but the product contains Phenylephrine HCI 5mg
Class III: Low Risk 08/04/2022 drug

Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.
Class III: Low Risk 07/07/2021 drug

Labeling: Not Elsewhere Classified The primary label contains the words "enteric coated" but the tablet is not enteric coated and should only say 'coated tablet'

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.